At the cellular level, our data showed that ATO upregulates cancer cells HLA-I expression and increases TCR cells IFN-γ production, iron and ROS accumulation, and loss of mitochondrial membrane potential (ΔΨm) during TCR-T killing. The gene discussed is IFNG; the disease is cancer.